(Updated - June 27, 2019 8:16 AM EDT)Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Zogenix, Inc. (ZGNX) PT Raised to $65 at Mizuho SecuritiesJune 28, 2019 7:36 AM Zogenix Announces FDA Agreement to Proceed with Resubmission of FINTEPLA® NDAJune 27, 2019 8:01 AM